Artizan Biosciences, Inc. Employee Directory
Research ServicesConnecticut, United States11-50 Employees
Artizan Biosciences is a biotechnology company focused on microbiome-centered precision therapeutics aimed at addressing the root causes of serious diseases driven by intestinal inflammation. Drawing on IgA-SEQ technology and Yale-level immunobiology expertise, it identifies microbial drivers of disease and develops interventions that inhibit specific microbial factors in the intestinal tract. The company pursues approaches that can be delivered as small molecules or monoclonal antibodies, with the goal of restoring intestinal balance and interrupting inflammatory cascades in carefully selected patient subgroups across gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases, as well as certain cancers. Based in New Haven, Connecticut, Artizan is a small to mid-sized biotechnology company focused on research services. Its lead program for inflammatory bowel disease is approaching clinical development and has established partnerships with Biohaven Pharmaceuticals, Brii Biosciences, and the Crohn’s & Colitis Foundation. In July 2022, Artizan announced a multi-year research collaboration with University Medical Center Utrecht and Microviable Therapeutics SL.